Showing results (1261-1270 of 1,342) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|February 23, 2026
Single-cell RNA sequencing suggests different progenitor lineages between IDH mutant and IDHwt gliomaIyad Alnahhas, Allison Kayne, Mehak Majid Khan, et al.
Neuro-Oncology Advances|March 4, 2026
Rethinking treatment de-escalation in elderly glioblastoma: Lessons from a multicenter real-world cohortOrit Furman, Eva Falah, Inbar Dvir, et al.
Neuro-Oncology Advances|March 2, 2026
Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implicationsAlice Gantner, Hélène Dubois-Pot-Schneider, Hélène Dumond
Neuro-Oncology Advances|March 2, 2026
Single-cell advances in the investigation of the pathogenesis and treatment of brain metastasisRobert S Porter, Clara Alves-Pereira, Priscilla K Brastianos
Neuro-Oncology Advances|March 2, 2026
Redefining the immune microenvironment of gliomas in the era of single-cell genomicsL Nicolas Gonzalez Castro, Vrishabhadev Sathish Kumar, Mario L Suva, et al.
Neuro-Oncology Advances|June 26, 2023
Deep proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-aminolevulinic acidSaicharan Ghantasala, Amruth Bhat, Unnati Agarwal, et al.
Neuro-Oncology Advances|February 27, 2026
Development and validation of the Home time and Overall survival after Metastatic spine tumor surgery Estimator (HOME score)Husain Shakil, Armaan K Malhotra, Christopher S Lozano, et al.
Neuro-Oncology Advances|March 18, 2026
Real-world outcomes for selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas in Japan: A 1-year interim analysisYoshihiro Nishida, Akiyo Kitajima, Tomonori Ishii
Neuro-Oncology Advances|February 5, 2024
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forwardEmily J Smith, Anant Naik, Mahima Goel, et al.
Neuro-Oncology Advances|February 23, 2024
Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: A systematic review and external pseudodata-based analysisGiacomo Sferruzza, Massimo Malcangi, Luca Bosco, et al.
Pageof 135